In addition, prostate cancer antigen 3 (PCA3), flotillin 2, Rab3B and late endosomal/lysosomal adaptor, MAPK and mTOR activator 1 (LAMTOR1) in EVs could be diagnostic markers for PCa [69,106]. The gene discussed is PCA3; the disease is posterior cortical atrophy.